Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Thrombosis
•
Hematology
•
Benign Hematology
•
Hemostasis/Thrombosis
•
Anticoagulation
How to manage a venous thromboembolism that developed while a patient was on warfarin for a mechanical valve?
Therapeutic INR
Related Questions
How do you approach the management of PFO in a young person with a cryptogenic CVA?
How would you manage a patient with new DVT while on dabigatran for atrial fibrillation who may have missed some doses of dabigatran around time of DVT?
In extremely obese patients with spontaneous DVT/PE who have been anticoagulated for > 6 months, do you feel comfortable reducing the DOAC to prophylactic dose or do you prefer continuing full dose indefinite anticoagulation?
How long do you anticoagulate for cirrhosis patients who have portal vein thrombosis extending to the mesenteric veins?
In a young female with severe osteoporosis due to congenital estrogen deficiency, can estrogen be prescribed if genetic testing for congenital disorders reveals a heterozygous Factor V Leiden mutation?
Would you recommend indefinite anticoagulation in any scenario of a provoked clot?
Are SCDs contraindicated in patients with acute DVTs?
How long post operatively do you wait before transitioning from parenteral anticoagulation to oral anticoagulants after pulmonary thromboendarterectomy for CTEPH?
How do you treat a patient with warfarin failure, with therapeutic INR 2-3 at the time of DVT, and no underlying malignancy or hypercoagulable state?
Are there any circumstances where you would consider bridging for patients on DOACs?
